---
title: "Male birth control options in phase II trials offer non-hormonal methods for men beyond condoms and vasectomy."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276375511.md"
description: "In Los Angeles on February 19, 2026, it was reported that there is a growing demand among men for alternative contraceptive methods beyond condoms and vasectomies. The focus is on non-hormonal options, with particular interest in long-acting reversible methods and short-term, on-demand solutions. NEXT Life..."
datetime: "2026-02-19T20:24:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276375511.md)
  - [en](https://longbridge.com/en/news/276375511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276375511.md)
---

# Male birth control options in phase II trials offer non-hormonal methods for men beyond condoms and vasectomy.

In Los Angeles on February 19, 2026, it was reported that there is a growing demand among men for alternative contraceptive methods beyond condoms and vasectomies. The focus is on non-hormonal options, with particular interest in long-acting reversible methods and short-term, on-demand solutions. NEXT Life...

### Related Stocks

- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [OLSI.US](https://longbridge.com/en/quote/OLSI.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)